Arkolith/Insider Trading/TMBR/Form 4

Mendelsohn Alan

Chief Medical OfficerTimber Pharmaceuticals, Inc. (TMBR) · full profile →Form 4 · filed Nov 24, 2021
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 23, 2021Buy(P)10K$0.47$5K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-001534) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML